Aethlon Medical, Inc.
AEMD · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4,464 | $34,780 | $62,442 | $172,397 |
| - Cash | $5,501 | $5,442 | $14,533 | $17,072 |
| + Debt | $650 | $940 | $1,209 | $729 |
| Enterprise Value | -$388 | $30,278 | $49,118 | $156,054 |
| Revenue | $0 | $0 | $574 | $294 |
| % Growth | – | -100% | 95.2% | – |
| Gross Profit | $0 | $0 | $574 | $294 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$13,038 | -$12,278 | -$11,658 | -$10,297 |
| % Margin | – | – | -2,030.1% | -3,500.5% |
| Net Income | -$13,388 | -$12,208 | -$12,030 | -$10,416 |
| % Margin | – | – | -2,094.9% | -3,540.9% |
| EPS Diluted | -85.8 | -48.6 | -58.6 | -70.6 |
| % Growth | -76.5% | 17.1% | 17% | – |
| Operating Cash Flow | -$7,646 | -$10,130 | -$10,505 | -$9,767 |
| Capital Expenditures | $0 | -$251 | -$943 | -$349 |
| Free Cash Flow | -$7,646 | -$10,381 | -$11,448 | -$10,116 |